Wang XL - Search Results

1

iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma.

Wang WS, Liu XH, Liu LX, Lou WH, Jin DY, Yang PY, Wang XL. Wang WS, et al. Among authors: wang xl. J Proteomics. 2013 Oct 8;91:453-65. doi: 10.1016/j.jprot.2013.06.032. Epub 2013 Jul 12. J Proteomics. 2013. PMID: 23851313

2

Identifying serum biomarkers for TACE therapy efficiency of hepatocellular carcinoma.

Li CY, Wang XL, Wang JH, Yan ZP, Gong GQ, Cheng JM, Chen Y, Liu LX, Li GP, Wang CG, Shi DH. Li CY, et al. Among authors: wang jh, wang xl, wang cg. Front Biosci (Elite Ed). 2011 Jan 1;3(1):212-20. doi: 10.2741/e235. Front Biosci (Elite Ed). 2011. PMID: 21196300 Free article.

3

Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.

Wang WS, Liu LX, Li GP, Chen Y, Li CY, Jin DY, Wang XL. Wang WS, et al. Among authors: wang xl. Cancer Prev Res (Phila). 2013 Apr;6(4):331-8. doi: 10.1158/1940-6207.CAPR-12-0307. Epub 2013 Feb 19. Cancer Prev Res (Phila). 2013. PMID: 23430754

4

Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics.

Wang WS, Liu XH, Liu LX, Jin DY, Yang PY, Wang XL. Wang WS, et al. Among authors: wang xl. J Proteomics. 2013 Jun 12;84:52-60. doi: 10.1016/j.jprot.2013.03.031. Epub 2013 Apr 6. J Proteomics. 2013. PMID: 23571023 Clinical Trial.

5

Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies.

Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, Gong G, Li G. Chen Y, et al. Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1395-408. doi: 10.1158/1055-9965.EPI-13-0042. Epub 2013 May 22. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23697611

6

Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer.

Chen Y, Wang XL, Wang JH, Yan ZP, Cheng JM, Gong GQ, Liu LX, Li GP, Li CY. Chen Y, et al. Among authors: wang jh, wang xl. Anticancer Drugs. 2014 Sep;25(8):958-63. doi: 10.1097/CAD.0000000000000120. Anticancer Drugs. 2014. PMID: 24800885

7

Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort.

Zhou G, Liu X, Wang X, Jin D, Chen Y, Li G, Li C, Fu D, Xu W, Wang X. Zhou G, et al. Onco Targets Ther. 2017 Feb 24;10:1199-1206. doi: 10.2147/OTT.S116136. eCollection 2017. Onco Targets Ther. 2017. PMID: 28280354 Free PMC article.

8

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.

Liu X, Zheng W, Wang W, Shen H, Liu L, Lou W, Wang X, Yang P. Liu X, et al. Br J Cancer. 2017 Dec 5;117(12):1846-1854. doi: 10.1038/bjc.2017.365. Epub 2017 Nov 9. Br J Cancer. 2017. PMID: 29123261 Free PMC article.

9

Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.

Pu N, Gao S, Xu Y, Zhao G, Lv Y, Nuerxiati A, Li JA, Wang D, Xu X, Kuang T, Wang X, Lou W, Liu L, Wu W. Pu N, et al. J Cancer. 2017 Sep 20;8(16):3362-3370. doi: 10.7150/jca.20917. eCollection 2017. J Cancer. 2017. PMID: 29158809 Free PMC article.

10

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.

Liu X, Zheng W, Wang W, Shen H, Liu L, Lou W, Wang X, Yang P. Liu X, et al. Br J Cancer. 2018 Mar 20;118(6):e15. doi: 10.1038/bjc.2018.5. Epub 2018 Feb 13. Br J Cancer. 2018. PMID: 29438371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,223 results

Search Page

Filters